ShareValue scores for MEDS: Valuation 56, Quality 43, Growth 50, Health 52.

MEDS
NASDAQ

DataMEDS AI, Inc.

$1.38(-7.38%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
56
Fair Value
Price vs Value
Quality
43
Moderate
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
25
Bearish
Price Trend

Company Details

About

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida. Address:

Score Analysis

AI Investment Thesis

Data as of:Aug 19, 2026
|
Last calculated:Aug 19, 2026